Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Leishen Energy Holding Co., Ltd. - Ordinary Shares (NQ:LSE)

5.215 +0.015 (+0.29%)
Streaming Delayed Price Updated: 9:32 AM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Leishen Energy Holding Co., Ltd. - Ordinary Shares

< Previous 1 2 Next >
Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting
From AVACTA GROUP PLC
Via GlobeNewswire
Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting
FAP-EXd (AVA6103) demonstrates tumor growth inhibition and durable complete responses in multiple therapy-resistant preclinical models 
From AVACTA GROUP PLC
Via GlobeNewswire
Nexxen Advances AI Capabilities, Launches ‘nexAI’
From Nexxen International Ltd.
Via GlobeNewswire
HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
HUTCHMED Completes Patient Enrollment of a Phase II Registration Study of Savolitinib in Gastric Cancer in China
From HUTCHMED (China) Limited
Via GlobeNewswire
Caledonia Mining Corporation Plc Blanket Mine Q1 2025 Production
Record Q1 gold production sets strong foundation for 2025 
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Caledonia completes sale of Solar Plant
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Nexxen Launches Health Offering to Reach Key Audiences with Accuracy and Scale
From Nexxen International Ltd.
Via GlobeNewswire
Leishen Energy Holding Co., Ltd is trying to make a strategic layout in Middle East as a production base for overseas market
From Leishen Energy Holding Co., Ltd.
Via GlobeNewswire
Alpha FMC Releases 2025 Asset & Wealth Management and Alternatives Outlooks: AI, Private Markets, and Regulatory Shifts Take Center Stage
From Alpha FMC
Via GlobeNewswire
Caledonia Mining Corporation Plc Issue of Securities Pursuant to Long Term Incentive Plan Awards and Issue of New Long Term Incentive Plan Awards
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives
From AVACTA GROUP PLC
Via GlobeNewswire
Caledonia Mining Corporation Plc: Results for the year ended December 31, 2024
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Caledonia Mining Corporation Plc: Change to payment date of Caledonia’s April dividend
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Caledonia Mining Corporation Plc: Bilboes Optimisation Update
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting
From AVACTA GROUP PLC
Via GlobeNewswire
Caledonia Mining Corporation Plc: Notice of Availability of AGM Materials
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Caledonia approves quarterly dividend
From Caledonia Mining Corporation Plc
Via GlobeNewswire
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
From HUTCHMED (China) Limited
Via GlobeNewswire
Caledonia Mining Corporation Plc: Short delay to the publication of financial results for the year ended December 31, 2024
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Intended Retirement of Independent Non-executive Directors and changes of composition of board committees
From HUTCHMED (China) Limited
Via GlobeNewswire
HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025
From HUTCHMED (China) Limited
Via GlobeNewswire
HUTCHMED Reports 2024 Full Year Results and Provides Business Updates
65% oncology products revenue growth drove profitable operation and supported new ATTC platform 
From HUTCHMED (China) Limited
Via GlobeNewswire
Nexxen Expands U.S. Partnership with Tubi to U.K.
Strategic partnership enhances advertiser engagement and monetisation in the growing U.K. streaming market 
From Nexxen International Ltd.
Via GlobeNewswire
HUTCHMED and Innovent Jointly Announce that the FRUSICA-2 Phase II/III Study of Fruquintinib and Sintilimab Combination Has Met its Primary Endpoint in Advanced Renal Cell Carcinoma in China
From HUTCHMED (China) Limited
Via GlobeNewswire
Executive Appointments Strengthen Nexxen’s Data, Streaming and Omnichannel Expertise
Strategic leadership hires enhance the company’s U.S. regional and global growth as well as its commitment to clients 
From Nexxen International Ltd.
Via GlobeNewswire
Caledonia Mining Corporation Plc: Notice of Results and Investor Presentation
From Caledonia Mining Corporation Plc
Via GlobeNewswire
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
From AVACTA GROUP PLC
Via GlobeNewswire
Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts
Encouraging Progression Free Survival (PFS) data observed in patients with salivary gland cancers compared to conventional treatments 
From AVACTA GROUP PLC
Via GlobeNewswire
HUTCHMED Announces that it has Completed Enrollment of a Phase II Registration Study of Fanregratinib (HMPL-453) for Intrahepatic Cholangiocarcinoma in China
From HUTCHMED (China) Limited
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.